Back
A Case of Sustained Objective Response of Recurrent/Progressive Diffuse Intrinsic Pontine Glioma with Phenylbutyrate and Targeted Agents
Stanislaw R. Burzynski, Gregory S. Burzynski, Sheldon Brookman
J. Cancer Ther. Vol.6 No.1, January 08, 2015  DOI: 10.4236/jct.2015.61006
       (PDF  2621K)     HTML      XML
Preliminary Findings on the Use of Targeted Therapy with Pazopanib and Other Agents in Combination with Sodium Phenylbutyrate in the Treatment of Glioblastoma Multiforme
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Sheldon Brookman
J. Cancer Ther. Vol.5 No.14, December 25, 2014  DOI: 10.4236/jct.2014.514144
       (PDF  3746K)     HTML      XML
Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Colorectal Cancer after Failure of Second-Line Therapy—A Potential Strategy for Improved Survival
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Sheldon Brookman
J. Cancer Ther. Vol.5 No.13, November 20, 2014  DOI: 10.4236/jct.2014.513128
       (PDF  3899K)     HTML      XML
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with High-Grade Glioma. Final Report (Protocol BT-06), and Review of Recent Trials
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek
J. Cancer Ther. Vol.5 No.6, May 26, 2014  DOI: 10.4236/jct.2014.56065
       (PDF  580K)     HTML     
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Brain Tumors. Final Report (Protocol BT-10)
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek
J. Cancer Ther. Vol.8 No.2, February 16, 2017  DOI: 10.4236/jct.2017.82015
       (PDF  452K)     HTML      XML
 
 
Top